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Mycobacterium avium subspecies 
paratuberculosis, the organism known 
to cause Johne’s disease, was among 
organisms studied by the Regional 
Dairy Quality Management Alliance 
which tracked endemic disease 
dynamics over time in Northeast dairy 
herds with well-characterized animals 
and herd management practices. The 
RDQMA project is in cooperation with 
USDA.
Since starting its research, the 
RDQMA has identifi ed MAP super-
shedders on study farms and have 
recognized the role that super-
shedders play in the creation of 
passive shedders.
“Over time, many passive shedders 
become infected with MAP in their 
intestinal tissues (adult infection),” states 
the RDQMA report. “We recognized that 
virtually all active shedders have the 
potential to become super-shedders and 
super-spreaders of MAP.” 
 In the most recent study, 
researchers sought to estimate the 
effect of Johne’s disease status on 
individual cow milk production using 
longitudinal data collected over a 
four-year period from three U.S. dairy 
herds enrolled in the RDQMA project. 
Quarterly ELISA serum testing, 
biannual fecal culture and culture of 
tissues at slaughter helped determine 
Johne’s disease status: uninfected, 
low shedding or high shedding. 
Milk production data were collected 
from the Dairy Herd Improvement 
Association, with the effect of Johne’s 
disease status on milk production 
analyzed.
Highlights of  the RDQMA report:
•  “Johne’s disease status was 
found to have a signifi cant effect on 
milk production, and this effect was 
not uniform across Johne’s disease 
status categories. Our data indicate 
that cows that eventually will show 
low and high shedding of MAP are 
out-producing MAP-negative animals 
in the herd. Although latent animals 
produce more milk than uninfected 
animals, that difference decreases 
over time in the latent infection state.”
•  “When an animal starts 
shedding low levels of MAP, the model 
predicts an initial milk production 
that is slightly higher than that of 
uninfected herdmates, but there is 
a greater rate of decrease in milk 
production compared with the latently 
infected animals.”
•  “Animals in the high-shedding 
category have a meaningfully lower 
milk production than uninfected 
herdmates, with large decreases in 
production over time when remaining 
in the herd.”
•  “Greater milk yield is evident 
during latency compared with 
uninfected herdmates, but the 
discrepancy in yield decreases as 
the disease progresses over time. 
This MAP-induced decrease in milk 
production is supported by the clinical 
progression of Johne’s disease.” 
•  “As the organism invades 
the intestinal epithelium and begins 
to affect nutrient absorption, feed 
effi ciency decreases and milk 
production in negatively affected.”
•  “This analysis provides strong 
support that Johne’s disease status 
affects milk production in all infected 
animals, with increasing losses in milk 
production as disease progresses.”
•  Culling decisions should be 
made “on an individual animal, 
economic level, particularly since 
animals shedding MAP also spread 
the infection through environmental 
contamination.”
Looking Closer at Super-Shedders
To better understand the 
epidemiology of Johne’s disease 
and MAP dynamics in dairy cattle, 
researchers used a DNA-based 
molecular subtyping technique. Using 
this technique with the observed 
MAP shedding level, they evaluated 
whether low shedders of MAP were 
passive shedding (pass-through) 
animals or whether they were truly 
infected and whether these animals 
were possible infected by the super-
shedders within the herd.
From among the 142 isolates from 
fecal and tissue samples from the 
(continued on page 4)
RDQMA fi nding: Johne’s disease status 
affects milk production in all infected 
animals, with increasing losses in milk 
production as disease progresses.
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baseline levels of infection. From 
there, a disease risk assessment was 
conducted, and management prac-
tices were put in place to help control 
on-farm spread of the disease.
“We know that animals are most 
susceptible to Johne’s infection at 
a very young age, so calf manage-
ment was our fi rst priority,” he says. 
“There is no cure for Johne’s, so the 
best  way to manage the disease is to 
prevent it.”
At the same time that Grooms was 
assembling his herds for the demon-
stration project, Galen Schalk, a dairy 
farmer in Hillman, Mich., encountered 
his herd’s fi rst diagnosed case of 
Johne’s disease.
“I had heard about Johne’s dis-
ease but thought, ‘That’s not me,’” 
Schalk says. “We have had a closed 
herd since 1974, so because I was not 
bringing new animals into the herd, 
I didn’t feel we were at risk for the 
disease.”
The fi rst Johne’s test from the 
Schalk’s herd, run at the request of 
his veterinarian, came back positive 
for Johne’s. The diagnosis concerned 
Schalk, who contemplated how many 
other cases he might have in the herd, 
so when Grooms approached him to 
be part of the Johne’s disease demon-
When the National Animal Health 
Monitoring System released its 
comprehensive report on Johne’s 
disease in 1997, the majority of dairy 
producers had only a general idea of 
what the disease was, and fewer still 
thought it affected their herds. But with 
an estimated 50% of the dairy animals 
in Michigan infected with Johne’s 
disease, there was no doubt it was a 
serious industry priority.  
Several Michigan State University 
researchers sought out funding to 
learn more about this economically 
damaging animal health issue, which 
has an estimated $200 million annual 
impact on the U.S. dairy industry.
Central to the initial research ef-
forts was Dan Grooms, MSU associate 
professor of large animal clinical sci-
ences and a large animal veterinarian.  
Along with learning more about the 
disease, Grooms and his colleagues 
from MSU and other universities would 
work for several years to determine 
the best management practices to 
employ on a dairy farm to prevent the 
spread of the disease and lower the 
percentage of animals infected (preva-
lence rate).
In 2003, researchers and veteri-
narians from the MSU Department of 
Animal Science, College of Veterinary 
Medicine and the Diagnostic Center 
for Population and Animal Health, 
and the Michigan Department of 
Agriculture joined researchers from 
16 other states to monitor dairy herd 
management practices. The Michigan 
team was chosen to be a part of the 
USDA’s National Johne’s Disease 
Demonstration Project. The purpose 
of the national project was to evaluate 
the long-term feasibility and effective-
ness of management-related prac-
tices designed to control infection by 
Mycobacterium avium paratuberculo-
sis (MAP), the causative organism for 
Johne’s disease.
Grooms selected seven herds to 
serve as his Johne’s disease demon-
stration herds. The herds, located in 
various regions of the state, under-
went whole-herd testing to measure 
stration project, Schalk did not hesitate 
to sign up.
“I had a very minimal understand-
ing of Johne’s and minimal prevention 
practices when we started with this 
project,” Schalk says.
The fi rst round of fecal cultures 
from the Schalk herd came back with 
a 21% prevalence rate among the 168 
animals tested; the second year, 2004, 
the rate jumped to 42%. The more 
Schalk learned about the disease and 
the test results on his herd, the more 
he realized that he had seen cows 
develop clinical signs of the disease 
in the past but hadn’t realized it was 
Johne’s.
(continued on page 3)
Researchers Team with Producers in Battle Against Johne’s
Calf management was the top priority of a seven-herd Michigan research project 
focused on best management practices to prevent the spread of Johne’s disease and 
lower the percentage of animals infected.
For information about 
Johne’s disease, 
contact your Designated Joh-
ne’s Coordinator 
Randy L. Wheeler, 
Randy.Wheeler@IowaAgriculture.gov,  
Ph (515) 281-0866 
or visit 
www.johnesdisease.org
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Johne’s Battle (continued)
“We would have cows get really 
thin and drop in productivity, so we 
would cull them from the herd,” Schalk 
says. “Now I know they were Johne’s 
animals.”
Seeing the high prevalence rate, 
Schalk was eager to eliminate the 
problem as quickly as possible. Shalk, 
Grooms and other MSU scientists put 
together new management strategies 
to help control the disease.
The area of highest concern on 
the Schalk farm was the calving area. 
Cows calved on a manure pack, which 
created the perfect environment for 
disease organisms to survive and 
spread to newborn calves. Though the 
Schalks had already drawn up build-
ing plans for a new transition barn, 
they opted instead to construct a new 
maternity and housing area for close-
up cows. 
“It was good that we were already 
looking to put up a new building be-
cause we really needed a better place 
for the animals to calve in,” Schalk says.
Along with building the new mater-
nity area, Schalk started withholding 
the colostrum from Johne’s-positive 
cows and feeding newborn calves co-
lostrum from only non-infected cows. 
“Johne’s can be transmitted to the 
calf through the colostrum or from the 
contaminated environment,” Grooms 
says. “Knowing which cows are posi-
tive for Johne’s is critical in stopping 
the disease from spreading.”
The new maternity area also 
provided an opportunity for each cow 
to calve in its own pen and allowed 
Schalk time to clean and disinfect 
each pen between calvings. Because 
animals contract Johne’s disease early 
in life, properly caring for calves is one 
of the most critical steps in preventing 
disease transmission, even though 
measuring immediate results from 
changing management practices is 
diffi cult. 
“Even though we culled a number 
of animals during the fi rst two years of 
the project, we still need to manage for 
the disease because we know some  
of the older animals are carriers,” 
Schalk says.
Visually identifying the Johne’s 
carriers helps Schalk manage the dis-
ease. Schalk now tags all animals that 
test positive for Johne’s disease with 
a special red neck chain. Any heifers 
born to positive dams are also tagged 
with the red neck chain until they re-
ceive a negative test reading. 
“It is not perfect,” Schalk says. 
“Occasionally an animal is born early 
in the close-up area and not in the as-
signed calving pen, but we are really 
making progress.”
Animals can shed the organ-
ism that causes Johne’s even if they 
are not showing clinical signs of the 
disease. Research indicated that the 
disease-causing organism is shed 
through the manure. So Schalk imple-
mented another critical management 
practice -- taking preventive measures 
to ensure that no manure comes in 
contact with animal feed. 
To prevent cross-contamination, 
the Schalks bought a second skid 
steer and use one only to clean and 
scrape manure and the other only 
to handle and move feed. They also 
make sure not to cross over feed al-
leys with equipment to minimize the 
risk of any manure on the tires coming 
into contact with the feed.
Since the Schalk herd became 
part of the Johne’s demonstration 
project, the prevalence of Johne’s in 
the herd has dropped to less than 5%. 
The results on this herd are similar to 
the outcomes realized by the other 
test herds.
“We saw a reduction in the num-
ber of Johne’s-positive animals in all 
the herds we worked with,” Grooms 
says. “This project shows us that, 
though there is no cure for Johne’s 
disease, with proper management 
farmers can prevent the spread of the 
disease on their farms and reduce its 
prevalence over time.”
As the demonstration project 
winds down, Schalk is looking ahead 
to how he will continue implement-
ing the recommended management 
practices on his farm. Now that he has 
the prevalence rate down to less than 
5 percent, he will continue to test the 
herd to monitor for any new infections.
“We were surprised to learn that 
we had the disease at all. If we don’t 
continue to test the herd, we won’t 
know if we’re continuing to make prog-
ress,” Schalk says. 
Funding for Grooms’ position with 
an emphasis on cattle disease man-
agement was made possible by the 
Animal Agriculture Initiative at MSU. 
The AAI was established in 1996 as 
part of the grass-roots-driven Revital-
ization of Animal Agriculture in Michi-
gan Initiative.
Reprinted with permission from the Michigan 
Farmer. Copyright 2009 © Farm Progress Cos. 
Researcher Dr. Dan Grooms notes that “this project shows us that, though there is no 
cure for Johne’s disease, with proper management, farmers can prevent the spread 
of the disease on their farms and reduce its prevalence over time.”
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Vaccine Project Underway
The Johne’s Disease Integrated Program, often referred to as JDIP, 
is a comprehensive consortium of scientists whose mission is to promote 
animal biosecurity through the development and support of projects 
designed to enhance knowledge, promote education, develop real-world 
solutions and mitigate losses associated with Johne’s Disease. By joining 
together, effi ciencies through collaborative research can be achieved 
and intellectual and physical resources critical to overall success can be 
shared. The consortium includes leading scientists in the fi eld, drawn from 
the world’s top academic and government institutions representing the 
diverse disciplines of microbiology, immunology, pathology, molecular and 
cellular biology, genomics, proteomics, epidemiology, clinical veterinary 
medicine, public health, extension and public policy.
Funding from USDA-CSREES-NRI allows JDIP to provide competitive 
awards for meritorious research, education and extension projects 
addressing Johne’s disease. Approximately $1 million will be distributed 
in the current funding cycle, with $400,000 designated for Johne’s disease 
diagnostics projects, and the remainder available across the remaining JDIP 
Core and Project areas.
testing centers at the University 
of Wisconsin and the University of 
Minnesota for blinded evaluation. 
 “The JDIP Epidemiology 
and Biostatistics Core at Cornell 
University will analyze the results 
of the testing in a blinded manner 
and identify the ‘best candidates’,” 
Cunningham states. “Once the 
analysis is complete and the blind 
is opened, all of the program 
participants will receive the data at 
the same time.”
 During Phase II of the vaccine-
testing program, “best candidates” 
will be evaluated using a mouse 
model. If all goes as planned, two 
laboratories will conduct the infection 
and protection studies in the mouse.
 Phase II will involve the “best 
candidates” identifi ed through the 
mouse studies being evaluated using 
a goat model.
 “This will provide data similar 
to that from cattle, but the data will 
be available in a much shorter time 
frame and at a lower cost,” states 
Robab Katani, a JDIP scientist with 
The Pennsylvania State University.
 “The coordinated three-stage 
three farms were 15 different strains: 
9 types on Farm A, 7 types on Farm 
B and 6 types on Farm C. The results 
indicated herd-specifi c infections: a 
clonal infection in Herd C with 89% of 
animals sharing the same strain (Type 
2) and different strains in Herds A and B.
Type 4 was the most predominate 
one on Farm A (59%), and most 
super-shedder isolates belonged to 
this type.
Farm B was found to have a 
variety of strains from a limited number 
of isolates, and animals from which 
these samples were collected were 
purchased from different sources.
On Farm C, 100% of the infected 
cows shed the same strain as that of 
contemporary super-shedders. On 
Farm A, 17% to 70% of cows shed the 
same strain as that of contemporary 
super-shedders. Tissues from about 
82% of cows other than super-
shedders were culture-positive for 
MAP, indicating a true infection.
Based on results of MAP strain-
typing and shedding levels, at least 
50% of low shedders have the same 
strain as that of a contemporary super-
shedder.
“The results of this study indicate 
that very few cows had characteristics 
of a possible pass-through animal. 
Many more cows were truly infected,” 
the researchers stated in their report. 
“Sharing of the same strain of low 
shedders with the contemporary 
super-shedders suggest that low 
shedders may be infected by the 
super-shedders.”
The next RDQMA research 
project: model the effi cacy of 
vaccination against Johne’s disease.
 With only one USDA-approved 
vaccine available to help protect 
against Johne’s disease, many 
veterinarians and producers would like 
more available vaccines—particularly 
since the current approved vaccine 
has limitations and is not approved 
for use in all states. With funding 
from USDA-APHIS-VS, the Johne’s 
Disease Integrated Program has 
undertaken an effort to identify viable 
vaccine candidates and evaluate 
those with the greatest potential for 
commercial development.
 “The project is in the initial stages 
of a three-step process,” states Tiffany 
Cunningham with JDIP. “Currently, 
JDIP is in Phase I of the vaccine-
testing program and has added an 
additional participating institution, 
AgResearch Limited, to the program.”
 As part of Phase I of the 
program, scientists have submitted 
strains of live vaccine candidates 
and recombinant proteins, and a 
laboratory at The Pennsylvania State 
University is coordinating the cultures 
and growing the strains that have 
been received. The strains will then 
be distributed to candidate vaccine-
evaluation will take approximately 
three years to complete. It is 
expected that this rigorous screening 
process will identify one or more 
viable candidates to move forward for 
commercial development.”
RDQMA (continued)
